A detailed history of Simplex Trading, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Simplex Trading, LLC holds 81 shares of CNTB stock, worth $144. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81
Holding current value
$144
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$1.01 - $1.74 $81 - $140
81 New
81 $0
Q4 2022

Feb 02, 2023

BUY
$0.64 - $0.87 $58 - $79
91 Added 10.08%
994 $0
Q3 2022

Nov 04, 2022

BUY
$0.8 - $1.65 $722 - $1,489
903 New
903 $1,000
Q2 2022

Aug 03, 2022

SELL
$0.56 - $3.25 $702 - $4,078
-1,255 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$2.46 - $5.92 $17,163 - $41,303
-6,977 Reduced 84.75%
1,255 $3,000
Q4 2021

Feb 23, 2022

BUY
$4.26 - $23.33 $35,068 - $192,052
8,232 New
8,232 $42,000

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $98.5M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.